Potentials and Challenges in Development of Vesicular Phospholipid Gel as a Novel Dermal Vehicle for Thymol.

IF 5.5 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Sabina Keser, Zora Rukavina, Marica Jozić, Lea Pavlović-Mitrović, Magda Vodolšak, Kristina Kranjčec, Darija Stupin Polančec, Gordana Maravić-Vlahoviček, Jasmina Lovrić, Maja Šegvić Klarić, Željka Vanić
{"title":"Potentials and Challenges in Development of Vesicular Phospholipid Gel as a Novel Dermal Vehicle for Thymol.","authors":"Sabina Keser, Zora Rukavina, Marica Jozić, Lea Pavlović-Mitrović, Magda Vodolšak, Kristina Kranjčec, Darija Stupin Polančec, Gordana Maravić-Vlahoviček, Jasmina Lovrić, Maja Šegvić Klarić, Željka Vanić","doi":"10.3390/pharmaceutics17070854","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives:</b> Thymol, one of the main compounds of thyme essential oil, has shown promising effects in treating various skin disorders owing to its anti-inflammatory, antimicrobial and antioxidative activities. Due to its limited solubility in water, thymol is commonly used in higher concentrations to achieve a suitable therapeutic effect, which can consequently lead to skin irritation. To overcome these limitations, we incorporated thymol into a vesicular phospholipid gel (VPG), a novel semisolid dermal vehicle consisting of highly concentrated dispersion of phospholipid vesicles (liposomes). <b>Methods:</b> Thymol was successfully loaded into two VPGs differing in bilayer fluidity, which were characterized for the physicochemical and rheological properties, storage stability, in vitro release, ex vivo skin permeability, in vitro compatibility with epidermal cells, wound healing potential, and antibacterial activity against skin-relevant bacterial strains. <b>Results:</b> High pressure homogenization method enabled preparation of VPG-liposomes of neutral surface charge in the size range 140-150 nm with polydispersity indexes below 0.5. Both types of VPGs exhibited viscoelastic solid-like structures appropriate for skin administration and ensured skin localization of thymol. Although both types of VPGs enabled prolonged release of thymol, the presence of cholesterol in the VPG increased the rigidity of the corresponding liposomes and further slowed down thymol release. <b>Conclusions:</b> Loading of thymol into VPGs significantly reduced its cytotoxicity toward human keratinocytes in vitro even at very high concentrations, compared to free thymol. Moreover, it facilitated in vitro wound healing activity, proving its potential as a vehicle for herbal-based medicines. However, the antibacterial activity of thymol against <i>Staphylococcus aureus</i> and methicillin-resistant <i>S. aureus</i> was hindered by VPGs, which represents a challenge in their development.</p>","PeriodicalId":19894,"journal":{"name":"Pharmaceutics","volume":"17 7","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2025-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12298122/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/pharmaceutics17070854","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: Thymol, one of the main compounds of thyme essential oil, has shown promising effects in treating various skin disorders owing to its anti-inflammatory, antimicrobial and antioxidative activities. Due to its limited solubility in water, thymol is commonly used in higher concentrations to achieve a suitable therapeutic effect, which can consequently lead to skin irritation. To overcome these limitations, we incorporated thymol into a vesicular phospholipid gel (VPG), a novel semisolid dermal vehicle consisting of highly concentrated dispersion of phospholipid vesicles (liposomes). Methods: Thymol was successfully loaded into two VPGs differing in bilayer fluidity, which were characterized for the physicochemical and rheological properties, storage stability, in vitro release, ex vivo skin permeability, in vitro compatibility with epidermal cells, wound healing potential, and antibacterial activity against skin-relevant bacterial strains. Results: High pressure homogenization method enabled preparation of VPG-liposomes of neutral surface charge in the size range 140-150 nm with polydispersity indexes below 0.5. Both types of VPGs exhibited viscoelastic solid-like structures appropriate for skin administration and ensured skin localization of thymol. Although both types of VPGs enabled prolonged release of thymol, the presence of cholesterol in the VPG increased the rigidity of the corresponding liposomes and further slowed down thymol release. Conclusions: Loading of thymol into VPGs significantly reduced its cytotoxicity toward human keratinocytes in vitro even at very high concentrations, compared to free thymol. Moreover, it facilitated in vitro wound healing activity, proving its potential as a vehicle for herbal-based medicines. However, the antibacterial activity of thymol against Staphylococcus aureus and methicillin-resistant S. aureus was hindered by VPGs, which represents a challenge in their development.

泡状磷脂凝胶作为一种新型百里酚皮肤载体的发展潜力和挑战。
背景/目的:百里香酚是百里香精油的主要成分之一,具有抗炎、抗菌和抗氧化作用,在治疗多种皮肤疾病方面具有良好的效果。由于其在水中的溶解度有限,百里香酚通常以较高的浓度使用,以达到适当的治疗效果,因此可能导致皮肤刺激。为了克服这些限制,我们将百里香酚加入到泡状磷脂凝胶(VPG)中,这是一种新型的半固体皮肤载体,由高度分散的磷脂囊泡(脂质体)组成。方法:将百里香酚成功加载到两种双层流动性不同的vpg中,对其理化和流变特性、储存稳定性、体外释放、体外皮肤渗透性、与表皮细胞的体外相容性、伤口愈合潜力和对皮肤相关菌株的抗菌活性进行了表征。结果:高压均质法制备的vpg -脂质体具有中性表面电荷,粒径在140 ~ 150 nm之间,多分散指数在0.5以下。两种类型的vpg都表现出适合皮肤给药的粘弹性固体样结构,并确保百里酚的皮肤定位。尽管两种类型的VPG都能延长百里香酚的释放,但VPG中胆固醇的存在增加了相应脂质体的刚性,并进一步减缓了百里香酚的释放。结论:与游离百里香酚相比,在体外,即使在非常高的浓度下,将百里香酚加载到VPGs中也能显著降低其对人角质形成细胞的细胞毒性。此外,它促进了体外伤口愈合活性,证明了其作为草药载体的潜力。然而,百里香酚对金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌的抑菌活性受到VPGs的抑制,这是其开发的一个挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutics
Pharmaceutics Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
7.90
自引率
11.10%
发文量
2379
审稿时长
16.41 days
期刊介绍: Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications,  and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信